Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

B vitamins, methionine and alcohol intake and risk of colon cancer in relation to BRAF mutation and CpG island methylator phenotype (CIMP).

Schernhammer ES, Giovannucci E, Baba Y, Fuchs CS, Ogino S.

PLoS One. 2011;6(6):e21102. doi: 10.1371/journal.pone.0021102. Epub 2011 Jun 27.

2.

CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci.

Kawasaki T, Ohnishi M, Nosho K, Suemoto Y, Kirkner GJ, Meyerhardt JA, Fuchs CS, Ogino S.

Mod Pathol. 2008 Mar;21(3):245-55. doi: 10.1038/modpathol.3800982. Epub 2008 Jan 18.

3.

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.

Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Meyerhardt JA, Loda M, Giovannucci EL, Fuchs CS.

Gut. 2009 Jan;58(1):90-6. doi: 10.1136/gut.2008.155473. Epub 2008 Oct 2.

4.

TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer.

Ogino S, Kawasaki T, Ogawa A, Kirkner GJ, Loda M, Fuchs CS.

Hum Pathol. 2007 Apr;38(4):614-20. Epub 2007 Jan 31.

PMID:
17270239
5.

Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample.

Nosho K, Irahara N, Shima K, Kure S, Kirkner GJ, Schernhammer ES, Hazra A, Hunter DJ, Quackenbush J, Spiegelman D, Giovannucci EL, Fuchs CS, Ogino S.

PLoS One. 2008;3(11):e3698. doi: 10.1371/journal.pone.0003698. Epub 2008 Nov 12.

6.

Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancer.

Tanaka N, Huttenhower C, Nosho K, Baba Y, Shima K, Quackenbush J, Haigis KM, Giovannucci E, Fuchs CS, Ogino S.

Am J Pathol. 2010 Dec;177(6):2731-40. doi: 10.2353/ajpath.2010.100361. Epub 2010 Oct 29.

7.

Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample.

Ogino S, Kawasaki T, Kirkner GJ, Kraft P, Loda M, Fuchs CS.

J Mol Diagn. 2007 Jul;9(3):305-14.

8.

Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer.

Slattery ML, Curtin K, Sweeney C, Levin TR, Potter J, Wolff RK, Albertsen H, Samowitz WS.

Int J Cancer. 2007 Feb 1;120(3):656-63.

9.

Correlation of laterally spreading type and JC virus with methylator phenotype status in colorectal adenoma.

Nosho K, Yamamoto H, Takahashi T, Mikami M, Hizaki K, Maehata T, Taniguchi H, Yamaoka S, Adachi Y, Itoh F, Imai K, Shinomura Y.

Hum Pathol. 2008 May;39(5):767-75. doi: 10.1016/j.humpath.2007.10.005. Epub 2008 Mar 4.

PMID:
18284934
10.

DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer.

Nosho K, Shima K, Irahara N, Kure S, Baba Y, Kirkner GJ, Chen L, Gokhale S, Hazra A, Spiegelman D, Giovannucci EL, Jaenisch R, Fuchs CS, Ogino S.

Clin Cancer Res. 2009 Jun 1;15(11):3663-71. doi: 10.1158/1078-0432.CCR-08-2383. Epub 2009 May 26.

11.

Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.

Dawson H, Galván JA, Helbling M, Muller DE, Karamitopoulou E, Koelzer VH, Economou M, Hammer C, Lugli A, Zlobec I.

Int J Cancer. 2014 May 15;134(10):2342-51. doi: 10.1002/ijc.28564. Epub 2013 Nov 13.

12.

CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels.

Lee S, Cho NY, Yoo EJ, Kim JH, Kang GH.

Arch Pathol Lab Med. 2008 Oct;132(10):1657-65. doi: 10.1043/1543-2165(2008)132[1657:CIMPIC]2.0.CO;2.

PMID:
18834226
13.

Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer.

Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, Murtaugh MA, Wolff RK, Slattery ML.

Gastroenterology. 2005 Sep;129(3):837-45.

PMID:
16143123
14.

Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer.

de Vogel S, Bongaerts BW, Wouters KA, Kester AD, Schouten LJ, de Goeij AF, de Bruïne AP, Goldbohm RA, van den Brandt PA, van Engeland M, Weijenberg MP.

Carcinogenesis. 2008 Sep;29(9):1765-73. doi: 10.1093/carcin/bgn074. Epub 2008 Mar 13.

PMID:
18339680
15.

Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.

Ogino S, Kawasaki T, Kirkner GJ, Ogawa A, Dorfman I, Loda M, Fuchs CS.

J Pathol. 2006 Oct;210(2):147-54.

PMID:
16850502
16.

Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer.

Samowitz WS, Albertsen H, Sweeney C, Herrick J, Caan BJ, Anderson KE, Wolff RK, Slattery ML.

J Natl Cancer Inst. 2006 Dec 6;98(23):1731-8.

PMID:
17148775
17.

Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype.

Nosho K, Kawasaki T, Chan AT, Ohnishi M, Suemoto Y, Kirkner GJ, Fuchs CS, Ogino S.

Histopathology. 2008 Nov;53(5):588-98. doi: 10.1111/j.1365-2559.2008.03161.x.

18.

Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea.

Kim KM, Lee EJ, Ha S, Kang SY, Jang KT, Park CK, Kim JY, Kim YH, Chang DK, Odze RD.

Am J Surg Pathol. 2011 Sep;35(9):1274-86. doi: 10.1097/PAS.0b013e318224cd2e.

PMID:
21836485
19.

IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG island methylator phenotype, and p53.

Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ, Fuchs CS, Ogino S.

Neoplasia. 2007 Dec;9(12):1091-8.

20.

Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP.

Ogino S, Kawasaki T, Kirkner GJ, Yamaji T, Loda M, Fuchs CS.

Mod Pathol. 2007 Jan;20(1):15-22. Epub 2006 Nov 3.

Supplemental Content

Support Center